Research & Development Showcase to be held in New York on November 29 at 1 pm. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALLO:
- Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform
- Oppenheimer emerging biotech analysts to hold analyst/industry conference call
- Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
- Allogene Therapeutics Announces Poster Presentation of Its Phase 1 UNIVERSAL Trial in Multiple Myeloma at the 64th Annual Meeting of the American Society of Hematology
- Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase